Cystadane
BETAINE
Manufacturer: Recordati Rare Diseases
FDA-Approved Indications (4)
Treatment of homocystinuria to decrease elevated homocysteine blood levels.
indicated for the treatment of homocystinuria to decrease elevated homocysteine blood concentrations
Population: pediatric and adult patients
indicated for the treatment of homocystinuria to decrease elevated homocysteine blood concentrations
Population: pediatric and adult patients
indicated for the treatment of homocystinuria to decrease elevated homocysteine blood concentrations
Population: pediatric and adult patients
Indications & Usage
1 INDICATIONS AND USAGE CYSTADANE ® is indicated for the treatment of homocystinuria to decrease elevated homocysteine blood concentrations in pediatric and adult patients. Included within the category of homocystinuria are: Cystathionine beta-synthase (CBS) deficiency 5,10-methylenetetrahydrofolate reductase (MTHFR) deficiency Cobalamin cofactor metabolism (cbl) defect CYSTADANE is a methylating agent indicated in pediatric and adult patients for the treatment of homocystinuria to decrease elevated homocysteine blood concentrations. Included within the category of homocystinuria are ( 1 ): Cystathionine beta-synthase (CBS) deficiency 5,10-methylenetetrahydrofolate reductase (MTHFR) deficiency Cobalamin cofactor metabolism (cbl) defect
💙 Support Programs
View all →Where shown, WAC (Wholesale Acquisition Cost) is an estimate only — your actual cost depends on your insurance plan. Always verify pricing with your pharmacy or insurer.